Compare DELL & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DELL | TMO |
|---|---|---|
| Founded | 1984 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.7B | 164.3B |
| IPO Year | 2013 | 1996 |
| Metric | DELL | TMO |
|---|---|---|
| Price | $404.27 | $472.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 18 |
| Target Price | $181.63 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 9.8M | 2.3M |
| Earning Date | 05-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.23% | 0.40% |
| EPS Growth | ★ 36.05 | 7.32 |
| EPS | ★ 5.24 | 4.43 |
| Revenue | ★ $113,538,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $26.19 | $6.55 |
| Revenue Next Year | $8.60 | $5.11 |
| P/E Ratio | ★ $78.04 | $106.93 |
| Revenue Growth | ★ 18.80 | 14.47 |
| 52 Week Low | $110.22 | $385.46 |
| 52 Week High | $469.47 | $643.99 |
| Indicator | DELL | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 66.36 | 49.62 |
| Support Level | $126.13 | $456.87 |
| Resistance Level | $469.47 | $494.30 |
| Average True Range (ATR) | 28.95 | 14.23 |
| MACD | -3.29 | 0.32 |
| Stochastic Oscillator | 60.94 | 30.10 |
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).